pubmed.ncbi.nlm.nih.gov

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost - PubMed

️Sat Jan 01 1994

Clinical Trial

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost

P K Sneed et al. Int J Radiat Oncol Biol Phys. 1994.

Abstract

Purpose: To study patterns of recurrence in patients with focal primary glioblastoma treated on Northern California Oncology Group protocol 6G-82-2 including surgery, focal external beam radiotherapy (59.4-60 Gy) with oral hydroxyurea followed by temporary brain implant with high-activity iodine-125 sources (50 Gy), and six cycles of chemotherapy with procarbazine, lomustine, and vincristine.

Methods and materials: Serial brain imaging scans were available for review in 25 of 34 patients with glioblastoma who underwent brain implant boost. Of 381 scans performed between the date of diagnosis and the date of death or last follow-up, 362 (95%) were re-reviewed. Disease progression was scored as local (within 2 cm of the implant site), separate within the brain parenchyma (> or = 2 cm from the implant site), subependymal, or systemic. Both initial and subsequent failures were scored.

Results: Three patients are 5-year survivors, without evidence of disease, at 267, 292, and 308 weeks. Of the 22 initial sites of failure, 17 (77%) were local, three (14%) were separate brain lesions (one of which was due in retrospect to multicentric disease at diagnosis), one (5%) subependymal, and one (5%) systemic. Five patients with local failure later had other sites of failure, including a separate brain lesion in 1, subependymal spread in 3, and both in 1. One patient with separate brain failure later had local progression and then subependymal spread.

Conclusion: Although there was a significant risk of separate brain lesions or subependymal spread over time, local tumor progression was the predominant pattern of failure.

PubMed Disclaimer

Cited by

Stereotactic radiosurgery versus combined stereotactic radiosurgery and bevacizumab for recurrent glioblastoma; a systematic review and meta-analysis of survival.
Habibi MA, Ghorbani M, Esmaeilian S, Tajvidi F, Nekutalaban P, Boskabadi AR, Alemi F, Zafari R, Mirjani MS, Eazi S, Minaee P. Habibi MA, et al. Neurosurg Rev. 2024 Jul 13;47(1):323. doi: 10.1007/s10143-024-02585-9. Neurosurg Rev. 2024. PMID: 39002028
Hypofractionated stereotactic radiotherapy for unifocal and multifocal recurrence of malignant gliomas.
McKenzie JT, Guarnaschelli JN, Vagal AS, Warnick RE, Breneman JC. McKenzie JT, et al. J Neurooncol. 2013 Jul;113(3):403-9. doi: 10.1007/s11060-013-1126-2. Epub 2013 Apr 16. J Neurooncol. 2013. PMID: 23589034 Clinical Trial.
Adjuvant stereotactic fractionated radiotherapy to the resection cavity in recurrent glioblastoma - the GlioCave study (NOA 17 - ARO 2016/3 - DKTK ROG trial).
Straube C, Scherb H, Gempt J, Kirschke J, Zimmer C, Schmidt-Graf F, Meyer B, Combs SE. Straube C, et al. BMC Cancer. 2018 Jan 3;18(1):15. doi: 10.1186/s12885-017-3928-7. BMC Cancer. 2018. PMID: 29298660 Free PMC article. Clinical Trial.
Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr.
Fedrigo CA, Grivicich I, Schunemann DP, Chemale IM, dos Santos D, Jacovas T, Boschetti PS, Jotz GP, Braga Filho A, da Rocha AB. Fedrigo CA, et al. Radiat Oncol. 2011 Nov 11;6:156. doi: 10.1186/1748-717X-6-156. Radiat Oncol. 2011. PMID: 22077956 Free PMC article.

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost - PubMed